412
Views
19
CrossRef citations to date
0
Altmetric
Review

Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy

&
Pages 1059-1075 | Received 13 Sep 2016, Accepted 24 Nov 2016, Published online: 08 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ercan Cacan & Zeliha C. Ozmen. (2020) Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells. Journal of Chemotherapy 32:4, pages 193-201.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now

Articles from other publishers (17)

En Ren, Yanfang Wang, Tingxizi Liang, Hanqi Zheng, Jiaqi Shi, Zesheng Cheng, Hongjun Li & Zhen Gu. (2023) Local Drug Delivery Techniques for Triggering Immunogenic Cell Death. Small Methods 7:9.
Crossref
Mathilde Bausart, Giulia Rodella, Mathilde Dumont, Bernard Ucakar, Kevin Vanvarenberg, Alessio Malfanti & Véronique Préat. (2023) Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice. Nanomedicine: Nanotechnology, Biology and Medicine 50, pages 102681.
Crossref
Qian Chen, Chunyan Li & Qiangbin Wang. (2023) Multifunctional Nano‐Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death. Small Methods 7:5.
Crossref
Gülin Renda & Didem Şöhretoğlu. 2023. Handbook of Dietary Flavonoids. Handbook of Dietary Flavonoids 1 19 .
Fanfei Meng, Jianping Wang, Yanying He, Gregory M. Cresswell, Nadia A. Lanman, L. Tiffany Lyle, Timothy L. Ratliff & Yoon Yeo. (2022) A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity. Proceedings of the National Academy of Sciences 119:22.
Crossref
Kishore Banik, Elina Khatoon, Choudhary Harsha, Varsha Rana, Dey Parama, Krishan Kumar Thakur, Anupam Bishayee & Ajaikumar B. Kunnumakkara. (2022) Wogonin and its analogs for the prevention and treatment of cancer: A systematic review. Phytotherapy Research 36:5, pages 1854-1883.
Crossref
André E. Nel, Kuo-Ching Mei, Yu-Pei Liao & Xiangsheng Liu. (2022) Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano 16:4, pages 5184-5232.
Crossref
Zhenzhen Chen, Qian Zhang, Qinbiao Huang, Zhihong Liu, Lingjun Zeng, Lingna Zhang, Xu Chen, Hongtao Song & Jialiang Zhang. (2022) Photothermal MnO2 nanoparticles boost chemo-photothermal therapy-induced immunogenic cell death in tumor immunotherapy. International Journal of Pharmaceutics 617, pages 121578.
Crossref
Michael P. Vincent, Justin O. Navidzadeh, Sharan Bobbala & Evan A. Scott. (2022) Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. Cancer Cell 40:3, pages 255-276.
Crossref
Andrey A. Vodyashkin, Marko George Halim Rizk, Parfait Kezimana, Anatoly A. Kirichuk & Yaroslav M. Stanishevskiy. (2021) Application of Gold Nanoparticle-Based Materials in Cancer Therapy and Diagnostics. ChemEngineering 5:4, pages 69.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Amirhossein Zabolian, Hossein Saleki, Mahdi Vasheghani Farahani, Soodeh Hamzehlou, Fatemeh Bakhtiari Far, Seyed Omid Sharifzadeh, Saeed Samarghandian, Haroon Khan, Amir Reza Aref, Milad Ashrafizadeh, Ali Zarrabi & Gautam Sethi. (2021) Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacological Research 171, pages 105759.
Crossref
Min Zhang, Zan Dai, Shevanuja Theivendran, Zhengying Gu, Liang Zhao, Hao Song, Yannan Yang & Chengzhong Yu. (2021) Nanotechnology enabled reactive species regulation in biosystems for boosting cancer immunotherapy. Nano Today 36, pages 101035.
Crossref
Magdalena Zaremba-Czogalla, Anna Jaromin, Katarzyna Sidoryk, Agnieszka Zagórska, Marcin Cybulski & Jerzy Gubernator. (2020) Evaluation of the In Vitro Cytotoxic Activity of Caffeic Acid Derivatives and Liposomal Formulation against Pancreatic Cancer Cell Lines. Materials 13:24, pages 5813.
Crossref
Gema Vivo‐Llorca, Vicente Candela‐Noguera, María Alfonso, Alba García‐Fernández, Mar Orzáez, Félix Sancenón & Ramón Martínez‐Máñez. (2020) MUC1 Aptamer‐Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple‐Negative Breast Cancer. Chemistry – A European Journal 26:69, pages 16318-16327.
Crossref
Takahiro Yamazaki, Aitziber Buqué, Marissa Rybstein, Jonathan Chen, Ai Sato & Lorenzo Galluzzi. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer 433 452 .
Rong Yang, Zhiwei Wang, Ying Yuan, Ting Qian & Qibing Zhou. (2019) cRGD target liposome delivery system promoted immunogenic cell death through enhanced anticancer potency of a thymidine conjugate under UVA activation as a cancer vaccine. European Journal of Medicinal Chemistry 167, pages 499-509.
Crossref
Roger Gilabert-Oriol, Gemma Ryan, Ada Leung, Natalie Firmino, Kevin Bennewith & Marcel Bally. (2018) Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response. International Journal of Molecular Sciences 19:10, pages 2922.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.